Literature DB >> 35308704

Analysis of People's Attitude Toward COVID-19 Vaccine and Its Information Sources in Thailand.

Takeshi Yoda1,2, Benjamas Suksatit3,4, Masaaki Tokuda5, Hironobu Katsuyama1.   

Abstract

Introduction Coronavirus disease 2019 (COVID-19) vaccine hesitancy has become a global problem. Therefore, we aimed to determine the relationship between the information sources on vaccines and the willingness of people to be vaccinated in Thailand. Methods A sample of 500 respondents was drawn from an Internet research panel, and a questionnaire survey was administered to evaluate respondents' willingness to be vaccinated by sex, age group, educational background, occupation, and presence of chronic diseases, as well as their information sources on COVID-19 vaccines. Descriptive statistics and logistic regression analysis were employed to assess the relationship between vaccine hesitancy/refusal and other variables. Results Our results demonstrated that 90.2% of the participants were either willing to vaccinate or were already vaccinated. By contrast, 6.0% were hesitant and 3.8% did not want to be vaccinated. Females, people with education less than master's/bachelor's degree or high school, day laborers, housewives, and unemployed were significantly related to vaccine hesitation/refusal. Furthermore, they were less likely than the vaccine willingness group to use information resources from the Ministry of Health, public health centers, or medical associations. Conclusions As vaccine hesitancy and refusal ratio were found to be substantially lower than in a previous study for Thailand and other countries, public authorities should poll the public to identify vaccine-hesitant populations and their reasoning and provide appropriate information directly to the general public.
Copyright © 2022, Yoda et al.

Entities:  

Keywords:  covid-19; information; thailand; vaccine hesitancy; vaccine willingness

Year:  2022        PMID: 35308704      PMCID: PMC8926488          DOI: 10.7759/cureus.22215

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


Introduction

Vaccines against coronavirus disease 2019 (COVID-19) were met with much skepticism when they were first introduced in the winter of 2020. Most of the skeptics were concerned that the time between the start of the pandemic and the development of the vaccine was too short and that the vaccine would not be effective or would cause unexpected adverse reactions [1,2]. Pfizer and Moderna have developed vaccines based on the latest technology using messenger RNA, the genetic information of SARS-CoV-2 [3]. Until now, most vaccines have been inactivated or weakened versions of the virus. Consequently, some skeptics spread rumors that the vaccination with this latest type of vaccine could trigger the extinction of the human race [4]. Compared with traditional communication channels, social media offers an unprecedented opportunity to spread anti-vaccination messages and allow communities to form around the anti-vaccine sentiment [5]. Thus, many researchers were worried about vaccine hesitation against COVID-19 [1,2,6]. However, vaccine expectations and willingness have increased as vaccines have been introduced in many countries, with a recognized preventive effect of more than 90%. In Japan, the willingness to be vaccinated before the introduction of the vaccine was 65.7% [7]; however, as the vaccination started, the willingness to be vaccinated increased and is now reported to be as high as 72.4% [8]. The vaccination coverage has reached 70% of the total population, and due to concerns over the spread of the Omicron strain, the third round of vaccination is now being administered by medical personnel. Meanwhile, vaccination against COVID-19 was also introduced in Thailand at a relatively early stage of the pandemic outbreak. The COVID-19 vaccine administered in Thailand was manufactured by Sinovac Biotech Ltd. and the vaccination commenced in February 2021. Given its weaker efficacy against the Delta strain, since October 2021, Thailand has gradually switched to other vaccines such as those manufactured by AstraZeneca and Pfizer [9]. According to a previous study employing an Internet survey conducted between March and April 2021, in Thailand, 55.6% of respondents evinced their interest in receiving vaccination [10]. This result was somewhat lower than the results in previous studies in other countries. For example, in a survey conducted in Bangladesh from December 2020 to January 2021, 74.6% of respondents indicated they intended to be vaccinated [11], and in the results of a consolidated survey in 17 countries worldwide, 87.2% of respondents stated that they wanted to be vaccinated [12,13]. Willingness to be vaccinated against COVID-19 is influenced by information on both the vaccine and COVID-19. The change in the willingness of people in Thailand to be vaccinated is thought to be because of the outbreak of the Omicron strain and changes in the types of vaccines available [10]. Therefore, in this study, we conducted an Internet survey in December 2021 to clarify the relationship between the sources of information on vaccines and the willingness of people to be vaccinated against COVID-19 in Thailand.

Materials and methods

We conducted this study in December 2021 in Thailand and employed the Internet research panel data from Global QiQUMO, which is operated by Cross Marketing Inc., Tokyo, Japan. More than 500,000 people were registered on this research panel in Thailand. The sample size was calculated using the following formula: n=λ2p(1-p)/d2 [14], where n is the sample size, λ is the confidence level, p is the response ratio, and d is the tolerance. We substituted λ=1.96, p=0.5, d=0.05, resulting in a minimum sample size of 384.16. We considered a larger margin to account for incomplete responses and had 500 respondents in total. The questionnaire sought the following information: (1) sex, (2) age, (3) occupation, (4) educational background, (5) presence of chronic diseases (excluding COVID-19 infection), (6) willingness to receive COVID-19 vaccine (derived from the question: “Would you be willing to be vaccinated against COVID-19?” or “Have you already completed the COVID-19 vaccination?” with the response options being Yes, Unsure, and No), (7) reasons for the previous answer (multiple answers), and (8) information sources for COVID-19 vaccines (multiple answers). These items were referenced and arranged based on previous Japanese studies [7,15]. Descriptive statistics were used to evaluate vaccine willingness by sex, age group, occupation, educational background, and the presence of chronic diseases. The reasons for wanting and not wanting/hesitating to be vaccinated were estimated by sex. The source of COVID-19 vaccine information was assessed by vaccine willingness. The chi-square test was applied to evaluate categorical variables. We also analyzed the characteristics of the main reasons for vaccine hesitancy and refusal through logistic regression analysis, with sex, age group, occupation, educational background, and the presence of chronic diseases as independent variables. The significance level was set at <0.05. JMP Pro 14.1.0 (SAS Institute Inc., Cary, NC, USA) was used for all the analyses. The study was approved by the Ethical Committee of the Kawasaki Medical School (Approval number: 5499-00). Implied consent was sought rather than formal written consent to ensure the anonymity of participants. The participants clicked on the “I agree” button before commencing the survey to indicate their consent.

Results

Of the 500 participants, 246 (49.2%) were males, and the average age was 36.1 years (standard deviation was 11.6). Other socio-demographic characteristics are presented in Table 1.
Table 1

Characteristics of respondents

    N %
Sex Males 246 49.2
Females 251 50.2
Others 3 0.6
Age group Under 19 years 23 4.6
20–29 years 143 28.6
30–39 years 143 28.6
40–49 years 124 24.8
50–59 years 52 10.4
Over 60 years 15 3.0
Chronic diseases None 342 68.4
One or more 158 31.6
Education Primary school 11 2.2
Junior high school 19 3.8
Senior high school 84 16.8
Vocational school 87 17.4
College/university 264 52.8
Graduate school 35 7.0
Occupation Self-employed 190 38.0
Company employee 160 32.0
Civil servant 46 9.2
Day laborer 27 5.4
Housewife/housekeeper 10 2.0
Student 39 7.8
Unemployed 15 3.0
Others 13 2.6
Overall, 451 (90.2%) out of 500 participants stated that they were either willing to be vaccinated or were already vaccinated against COVID-19. Another 30 (6.0%) participants replied that they were not sure and 19 (3.8%) stated that they did not intend to get vaccinated. As illustrated in Table 2, we found considerable differences in the willingness to get vaccinated across gender, educational background, and occupation.
Table 2

Willingness to be vaccinated against COVID-19 by characteristics

*Pearson's chi-square test

    Yes (%) Unsure (%) No (%) p-Value*
Sex Males 234 (68.0) 10 (18.6) 2 (13.4) <0.01
Females 214 (63.2) 20 (25.8) 17 (11.0)
Others 3 (100.0) 0 (0.0) 0 (0.0)
Age group Under 19 years 16 (69.6) 4 (17.4) 3 (13.0) 0.09
20–29 years 132 (92.3) 6 (4.2) 5 (3.5)
30–39 years 133 (93.0) 7 (4.9) 3 (2.1)
40–49 years 108 (87.1) 10 (8.1) 6 (4.8)
50–59 years 48 (92.3) 2 (3.85) 2 (3.85)
Over 60 years 14 (93.3) 1 (6.7) 0 (0.0)
Chronic diseases None 308 (90.0) 21 (6.2) 13 (3.8) 0.98
One or more 143 (90.5) 9 (5.7) 6 (3.8)
Education Primary school 6 (54.5) 3 (27.3) 2 (18.2) <0.01
Junior high school 13 (68.4) 4 (21.1) 2 (10.5)
Senior high school 79 (94.0) 3 (3.6) 2 (2.4)
Vocational school 79 (90.8) 6 (6.9) 2 (2.3)
College/university 241 (91.3) 14 (5.3) 9 (3.4)
Graduate school 33 (94.3) 0 (0.0) 2 (5.7)
Occupation Self-employed 175 (92.1) 5 (2.6) 10 (5.3) <0.01
Company employee 154 (96.3) 6 (3.7) 0 (0.0)
Civil servant 43 (93.5) 2 (4.3) 1 (2.2)
Day laborer 19 (70.4) 6 (22.2) 2 (7.4)
Housewife/housekeeper 6 (60.0) 3 (30.0) 1 (10.0)
Student 35 (89.7) 3 (7.7) 1 (2.6)
Unemployed 10 (66.7) 4 (26.7) 1 (6.6)
Others 9 (69.2) 1 (7.8) 3 (23.0)

Willingness to be vaccinated against COVID-19 by characteristics

*Pearson's chi-square test Relatively higher rates of hesitation and refusal to be vaccinated against COVID-19 were found among females (36.8%, chi-square test, p<0.01), those under 19 years of age (30.4%, p=0.09, not significant), those whose educational background was primary school or junior high school (45.5% and 31.6%, respectively, p<0.01), and day laborers, housewives, and unemployed (29.6%, 40.0%, and 33.3%, respectively, p<0.01). We asked participants who were willing to get vaccinated about their main reasons (Figure 1).
Figure 1

Participants’ reasons for wanting to get vaccinated or having already vaccinated against COVID-19 (n=451; multiple answers)

Approximately two-thirds of the participants thought that vaccination was an effective and a strong tool to prevent COVID-19 infection both for themselves (N=301, 66.7%) and for the people around them (N=252, 55.8%). However, a little over one-fifth of the participants (N=99, 21.9%) thought that after vaccination, they did not need to continue engaging in preventive measures such as social distancing and using masks. We asked participants who were either unsure or did not want to be vaccinated against COVID-19 about the main reasons for this stance (Figure 2). Nearly two-thirds responded that they were concerned about the potential side effects of a vaccine (N=32, 65.3%). The second reason for vaccine hesitation or refusal was doubting the safety of the vaccine (N=28, 57.1%). Nearly half of the participants did not trust vaccine efficacy (N=25, 51.0%).
Figure 2

Reasons provided by participants who were either unsure or did not want to be vaccinated against COVID-19 (n=49; multiple answers)

We asked participants about their sources of information on the COVID-19 vaccine (Figure 3). The sources of information between respondents who were willing to be vaccinated and those who were hesitant or refused to receive the vaccination differed greatly for the Ministry of Health’s (MOH’s) website (47.2% vs. 20.4%), the websites of medical associations and/or public health centers (34.1% vs. 20.4%), and publicity or direct visit by officers from the local government and/or public health centers (39.2% vs. 14.3%). The percentage of users of the above three information sources was higher among those who were willing to be vaccinated than among those who hesitated or refused vaccination.
Figure 3

Sources of information on COVID-19 vaccine by vaccine willingness (n=451) and hesitation or refusal (n=49)

Bar charts represent percentages (multiple answers)

TV, television, SNS; Social Networking Service; WHO, World Health Organization; CDC, Centers for Diseases Control and Prevention

Sources of information on COVID-19 vaccine by vaccine willingness (n=451) and hesitation or refusal (n=49)

Bar charts represent percentages (multiple answers) TV, television, SNS; Social Networking Service; WHO, World Health Organization; CDC, Centers for Diseases Control and Prevention Furthermore, logistic regression analyses revealed that sex (male vs. female [OR: 2.79, 95% CI: 1.25-6.22]), educational background (primary school vs. senior high school [OR: 0.13, 95% CI: 0.02-0.79]), and occupation (self-employed vs. day laborer [OR: 4.89, 95% CI: 1.53-15.56] self-employed vs. housewife/housekeeper [OR: 8.31, 95% CI: 1.87-36.88], self-employed vs. unemployed [OR: 6.35, 95% CI: 1.57-25.72]) were significant factors associated with hesitating or refusing COVID-19 vaccine (Table 3).
Table 3

Results of logistic regression analysis with vaccine hesitation/refusal as dependent variables

*“Others” were deleted because the number was too small to analyze.

Akaike’s information criterion, corrected (AICc): 295.78; Bayesian information criterion (BIC): 378.19; R2 = 0.206

AOR, adjusted odds ratio; CI, confidence interval

  AOR95% CIp-Value
Gender*Males1- 
Females2.791.25–6.22<0.01
Age groupUnder 19 years1- 
20–29 years0.240.04–1.220.08
30–39 years0.280.05–1.560.15
40–49 years0.750.14–4.080.74
50–59 years0.380.05–2.770.34
Over 60 years0.470.03–6.930.58
Chronic diseasesNone1- 
One or more0.860.41–1.840.71
EducationPrimary school1- 
Junior high school0.700.10–4.790.72
Senior high school0.130.02–0.790.02
Vocational school0.210.03–1.140.07
College/university0.240.04–1.240.08
Graduate school0.110.01–1.010.05
OccupationSelf-employed1- 
Company employee0.460.16–1.280.13
Civil servant1,140.29–4.440.84
Day laborer4.891.53–15.56<0.01
Housewife/housekeeper8.311.87–36.88<0.01
Student0.730.14–3.700.70
Unemployed6.351.57–25.72<0.01
Others3.870.88–17.040.07

Results of logistic regression analysis with vaccine hesitation/refusal as dependent variables

*“Others” were deleted because the number was too small to analyze. Akaike’s information criterion, corrected (AICc): 295.78; Bayesian information criterion (BIC): 378.19; R2 = 0.206 AOR, adjusted odds ratio; CI, confidence interval

Discussion

In this study, an extremely large proportion of participants (90.2%) expressed their willingness to vaccinate or had already been vaccinated against COVID-19 compared with 55.6% reported in a previous study for Thailand [11], although their study period was much earlier than ours. A comparison of similar surveys in other countries reveals that the share in Japan ranged from 47% to 70% [7,8,16] and in China from 34% to 82% [17-19]. No other survey had reported that more than 90% of the respondents were willing to be vaccinated except for the USA survey [13,14]. The possible reasons for such a high rate of vaccine willingness in Thailand are as follows. First is the prevalence of the Omicron strain. The survey was conducted in the first week of December 2021, which coincides with the global outbreak of the Omicron strain [20]. Although the actual situation of this new mutant strain has not yet been clarified, it is reported to be more infectious than the delta variant [21]. This information may have increased the willingness to vaccinate. Second, the number of vaccinated people around the world has increased, leading to an increase in the availability of information on the efficacy and safety of vaccines. In particular, various studies on vaccine efficacy have demonstrated extremely high efficacy rates [3,22-24], and the increased credibility of these studies may have contributed to the higher willingness to vaccinate. Third, people felt forced by peer pressure to vaccinate. As evident in Figure 1, one-third of the participants responded, "People around me get vaccinated, so I should get vaccinated myself." Vaccination should be a decision based on one's own judgment and should not be forced. COVID-19 vaccination is not mandatory in Thailand. However, in some countries, vaccination has become compulsory [24,25], or a system has been established in which people cannot travel without vaccination [26-28]. Even if no such compulsion exists, if the majority of the people around one person are vaccinated, remaining unvaccinated will be difficult for that person as they will feel social pressure. The vaccination itself plays an important role in the prevention of COVID-19 infection; however, sometimes excessive demands for vaccination may lead to attacks on those who cannot be vaccinated because of reasons such as adverse reactions. Therefore, acting with caution is necessary. By contrast, approximately 10% of the participants hesitated or refused to get vaccinated against COVID-19. Their main reasons for hesitation or refusal were potential side effects and safety concerns. These have also been pointed out as major reasons in previous studies [7,8,15]. The possible resolution to overcome this challenge is to properly disclose the correct information. Many researchers and government agencies (such as MOH, public health office) have shared information on adverse events as well as the efficacy of COVID-19 vaccines [29,30]. However, as illustrated in Figure 3, the vaccine hesitation/refusal group did not use the governmental information network as much as the vaccination willingness group. Even if accurate information is provided by the MOH and public health centers, it cannot be conveyed without the public accessing that information source. Furthermore, a logistic regression analysis of factors associated with vaccine hesitancy/refusal indicated education and occupation as significant variables. The odds ratio of hesitation was higher when the educational background was elementary school compared to senior high school. The odds ratio was also significantly higher if the occupation was that of a day laborer, housewife/housekeeper, or unemployed. We also found that hesitation/refusal was higher among females than males. Our analysis of sources of information on the COVID-19 vaccine showed that people with vaccine hesitancy/refusal have less access to sources of information such as the MOH and medical associations compare with vaccine willingness. These findings suggest that the vaccine hesitancy group is not being provided with accurate information. We believe that the proactive provision of correct information not only to the public but also to these vulnerable people is necessary to overcome vaccine hesitancy. Our study has some limitations. First, this study was Internet-based; hence, we could not eliminate the selection bias. Second, this study was a cross-sectional study, and, therefore, no causality could be established. In addition, participants may have been affected by the available information on COVID-19 at the time of the survey (first week of December 2021). The questionnaire was designed to be simple; thus, we could not evaluate other sociodemographic factors such as income, details of residence, and habits.

Conclusions

Despite the aforementioned limitations, our study revealed that a very large number of people in Thailand are either willing to be vaccinated or have been already vaccinated against COVID-19, unlike the previous study in Thailand and other countries. Furthermore, the characteristics of people hesitating or refusing the vaccine and their sources of information were also revealed. Those who were hesitant or refused the COVID-19 vaccine were less likely to use the MOH website, governmental information such as publicities from local government offices and public health centers, and information from medical associations. Therefore, public authorities such as the MOH and public health offices should provide appropriate information directly to these vulnerable people.
  27 in total

1.  The online competition between pro- and anti-vaccination views.

Authors:  Neil F Johnson; Nicolas Velásquez; Nicholas Johnson Restrepo; Rhys Leahy; Nicholas Gabriel; Sara El Oud; Minzhang Zheng; Pedro Manrique; Stefan Wuchty; Yonatan Lupu
Journal:  Nature       Date:  2020-05-13       Impact factor: 49.962

2.  Interaction between age and health conditions in the intention to be vaccinated against COVID-19 in Thailand.

Authors:  Sakun Boon-Itt; Nopadol Rompho; Sompong Jiarnkamolchurn; Yukolpat Skunkan
Journal:  Hum Vaccin Immunother       Date:  2021-10-06       Impact factor: 4.526

3.  COVID-19 vaccine passport for safe resumption of travel.

Authors:  Androula Pavli; Helena C Maltezou
Journal:  J Travel Med       Date:  2021-06-01       Impact factor: 8.490

4.  Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys.

Authors:  Kailu Wang; Eliza Lai-Yi Wong; Kin-Fai Ho; Annie Wai-Ling Cheung; Peter Sen-Yung Yau; Dong Dong; Samuel Yeung-Shan Wong; Eng-Kiong Yeoh
Journal:  Vaccines (Basel)       Date:  2021-01-18

5.  The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020.

Authors:  Sara E Oliver; Julia W Gargano; Mona Marin; Megan Wallace; Kathryn G Curran; Mary Chamberland; Nancy McClung; Doug Campos-Outcalt; Rebecca L Morgan; Sarah Mbaeyi; José R Romero; H Keipp Talbot; Grace M Lee; Beth P Bell; Kathleen Dooling
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-12-18       Impact factor: 17.586

6.  Vaccine Hesitancy: COVID-19 and Influenza Vaccine Willingness among Parents in Wuxi, China-A Cross-Sectional Study.

Authors:  Qiang Wang; Shixin Xiu; Shuangyu Zhao; Jianli Wang; Ying Han; Shuheng Dong; Jinxin Huang; Tingting Cui; Liuqing Yang; Naiyang Shi; Minqi Liu; Yue Han; Xuwen Wang; Yuan Shen; Enpin Chen; Bing Lu; Hui Jin; Leesa Lin
Journal:  Vaccines (Basel)       Date:  2021-04-01

7.  Willingness to vaccinate against COVID-19 among Bangladeshi adults: Understanding the strategies to optimize vaccination coverage.

Authors:  Minhazul Abedin; Mohammad Aminul Islam; Farah Naz Rahman; Hasan Mahmud Reza; Mohammad Zakir Hossain; Mohammad Anwar Hossain; Adittya Arefin; Ahmed Hossain
Journal:  PLoS One       Date:  2021-04-27       Impact factor: 3.240

8.  Assessing COVID-19 Vaccine Hesitancy, Confidence, and Public Engagement: A Global Social Listening Study.

Authors:  Zhiyuan Hou; Yixin Tong; Fanxing Du; Linyao Lu; Sihong Zhao; Kexin Yu; Simon J Piatek; Heidi J Larson; Leesa Lin
Journal:  J Med Internet Res       Date:  2021-06-11       Impact factor: 5.428

9.  Gender differences in the determinants of willingness to get the COVID-19 vaccine among the working-age population in Japan.

Authors:  Tomohiro Ishimaru; Makoto Okawara; Hajime Ando; Ayako Hino; Tomohisa Nagata; Seiichiro Tateishi; Mayumi Tsuji; Shinya Matsuda; Yoshihisa Fujino
Journal:  Hum Vaccin Immunother       Date:  2021-07-02       Impact factor: 4.526

View more
  3 in total

1.  Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients.

Authors:  Napun Sutharattanapong; Sansanee Thotsiri; Surasak Kantachuvesiri; Punlop Wiwattanathum
Journal:  Vaccines (Basel)       Date:  2022-04-08

2.  The Relationship between Sources of COVID-19 Vaccine Information and Willingness to Be Vaccinated: An Internet-Based Cross-Sectional Study in Japan.

Authors:  Takeshi Yoda; Benjamas Suksatit; Masaaki Tokuda; Hironobu Katsuyama
Journal:  Vaccines (Basel)       Date:  2022-06-29

3.  COVID-19 Vaccination Willingness in Four Asian Countries: A Comparative Study including Thailand, Indonesia, the Philippines, and Vietnam.

Authors:  Kiyoko Saito; Makiko Komasawa; Myo Nyein Aung; Ei Thinzar Khin
Journal:  Int J Environ Res Public Health       Date:  2022-09-27       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.